First Citizens Bank & Trust Co. Has $3.05 Million Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

First Citizens Bank & Trust Co. boosted its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 1.1% in the fourth quarter, Holdings Channel reports. The fund owned 38,956 shares of the company’s stock after acquiring an additional 419 shares during the period. First Citizens Bank & Trust Co.’s holdings in GE HealthCare Technologies were worth $3,046,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently bought and sold shares of the company. LGT Financial Advisors LLC lifted its position in GE HealthCare Technologies by 1,673.3% during the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock worth $25,000 after acquiring an additional 251 shares during the last quarter. Capital Performance Advisors LLP acquired a new position in GE HealthCare Technologies during the 3rd quarter worth $26,000. Ashton Thomas Securities LLC acquired a new position in GE HealthCare Technologies during the 3rd quarter worth $26,000. Darwin Wealth Management LLC acquired a new position in GE HealthCare Technologies during the 3rd quarter worth $31,000. Finally, Continuum Advisory LLC lifted its position in GE HealthCare Technologies by 101.8% during the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock worth $31,000 after acquiring an additional 168 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Insiders Place Their Bets

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of the company’s stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total transaction of $309,338.96. Following the sale, the chief executive officer now directly owns 24,298 shares of the company’s stock, valued at approximately $2,101,291.04. This represents a 12.83 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.27% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have weighed in on GEHC. Wells Fargo & Company boosted their target price on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research report on Thursday, October 31st. Evercore ISI boosted their price objective on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a report on Tuesday, October 1st. Stifel Nicolaus boosted their price objective on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a “buy” rating in a report on Monday, September 30th. Finally, Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. One analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $96.00.

GE HealthCare Technologies Stock Performance

NASDAQ GEHC opened at $88.67 on Monday. The stock has a market cap of $40.51 billion, a P/E ratio of 24.36, a PEG ratio of 2.88 and a beta of 1.11. The company’s 50-day simple moving average is $82.32 and its 200 day simple moving average is $84.78. GE HealthCare Technologies Inc. has a twelve month low of $71.42 and a twelve month high of $94.55. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.14 earnings per share for the quarter, topping the consensus estimate of $1.06 by $0.08. The firm had revenue of $4.86 billion for the quarter, compared to analysts’ expectations of $4.87 billion. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The company’s quarterly revenue was up .9% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.99 earnings per share. As a group, research analysts forecast that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be paid a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.16%. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. The ex-dividend date of this dividend is Tuesday, January 14th. GE HealthCare Technologies’s dividend payout ratio is currently 3.85%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.